High mobility group A2 (HMGA2) protein tissue levels and its association with clinicopathological features in bladder cancer patients.

Alsoufi F, Zetoune AB

Open source

DOI
10.1007/s12672-025-03462-7
Published
2025 Aug 25
Container
Discover oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12672-025-03462-7,
  title = {High mobility group A2 (HMGA2) protein tissue levels and its association with clinicopathological features in bladder cancer patients.},
  author = {Alsoufi F and Zetoune AB},
  year = {2025},
  journal = {Discover oncology},
  doi = {10.1007/s12672-025-03462-7},
  url = {https://doi.org/10.1007/s12672-025-03462-7}
}

RIS

TY  - JOUR
TI  - High mobility group A2 (HMGA2) protein tissue levels and its association with clinicopathological features in bladder cancer patients.
AU  - Alsoufi F
AU  - Zetoune AB
PY  - 2025
JO  - Discover oncology
DO  - 10.1007/s12672-025-03462-7
UR  - https://doi.org/10.1007/s12672-025-03462-7
ER  - 

APA

F, A., & AB, Z. (2025). High mobility group A2 (HMGA2) protein tissue levels and its association with clinicopathological features in bladder cancer patients.. Discover oncology. https://doi.org/10.1007/s12672-025-03462-7

Source records